Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 trial of Cytisinicline in e-Cigarette Cessation

Next Previous
X
Search
Trial Profile

A Phase 2 trial of Cytisinicline in e-Cigarette Cessation

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 20 May 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cytisinicline (Primary)
  • Indications Smoking withdrawal
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ORCA-V1
  • Sponsors Achieve Life Sciences

    • Most Recent Events

    • 17 May 2024 According to an Achieve Life Sciences Media Release, company announced data from the Phase 2 ORCA-V1 vaping cessation trial will be presented today, Friday, May 17, 2024, at the Society of General Internal Medicine (SGIM) Annual Meeting being held in Boston, MA.
    • 06 May 2024 According to an Achieve Life Sciences Media Release, company expects to conduct an End-of-Phase 2 Meeting with the FDA later this year to discuss Phase 3 trial plans.
    • 06 May 2024 According to an Achieve Life Sciences Media Release, data from this study was presented in the Journal of the American Medical Association(JAMA) Internal Medicine.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top